proto-oncogene

You have access
C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target
PITHI CHANVORACHOTE, NICHARAT SRIRATANASAK and NONGYAO NONPANYA

Anticancer Research February 2020, 40 (2) 609-618; DOI: https://doi.org/10.21873/anticanres.13990
You have access
Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation
KAZUKI OTSUKA, MANABU SASADA, YU HIRANO, YUSUKE NOHARA, TAKUYA IYODA, YOSHIKAZU HIGAMI, HIROAKI KODAMA and FUMIO FUKAI

Anticancer Research July 2019, 39 (7) 3487-3492; DOI: https://doi.org/10.21873/anticanres.13494

Main menu